DuPont

Industrial Solutions

Industry-leading portfolio positioned

for growth

Investor Presentation
March 3, 2022
Industrial Solutions: BY GEOGRAPHY(1)
At a glance
BY PRODUCT LINE

Precision Parts & Solutions

30% 19%
47%
Healthcare & Spec Lubricants
$1.9 B(1)
Display Technologies

Advanced Printing
4%

BY MARKET SEGMENT
Semiconductor

Display & Lighting

Healthcare
$1.9 B(1)
Transportation & Aerospace

Industrial
~2,200 21 ~5%
Printing & Packaging COLLEAGUES MANUFACTURING R&D/REVENUE
SITES

(1) Reflects 2021 net sales of the Industrial Solutions business 2

Industrial Solutions: At a glance
STRONG FINANCIAL PROFILE AND GROWTH STRATEGY

NET SALES GROWTH STRATEGY

~7% Organic CAGR(1)

70% of business supports Invest in leading-edge
growth markets technology and
manufacturing capacity

Partner with customers Locate R&D, application

2019 2020 2021 to optimize system engineering, and
performance manufacturing close to
• Consistent top-line growth of approximately 5 to 7 percent with customer
strong cash flow
• Resilient sales based on customer-specified products in Leverage global Expand the addressable
healthcare, electronics, aerospace, and automotive footprint and operations market through targeted
excellence M&A
• Diverse end-market exposure enables stable performance
through the cycle
• Industry-leading profitability across all product lines

(1) Compound annual growth rate from 2019-2021 3

Industry-leading portfolio, well-positioned for growth
• High-Performance • Polyimide • Flexographic • Water-Based
Elastomer Shapes & Printing Plates Inkjet Inks
BROAD, Precision Parts O-Rings & Parts Parts Advanced & Equipment
CUSTOMIZED & Solutions Printing
PORTFOLIO Artistri®
ENABLES • Silicone Materials & • Specialty • OLED Emitting • Liquid
OPTIMIZED Adhesives Lubricants Materials Polyimides
Healthcare &
SOLUTIONS Specialty • Pharma Ingredients Display • Passivation • LED
Lubricants & Excipients Technologies Materials Encapsulants

Electronics Healthcare Aerospace Transportation Industrial

DIVERSE
EXPOSURE
TO MULTIPLE
ATTRACTIVE
END-USE
MARKETS OF
SOURCES
COMPETITIVE
ADVANTAGE
GROWTH DRIVEN BY GLOBAL MEGA TRENDS AND $10B+ ADDRESSABLE MARKET

4
DuPont Kalrez® high-performance elastomer parts
Sales Distribution by Segment DUPONT KALREZ® O-RINGS IN A MATERIALS PARTNER FOR
SEMI FAB PROCESS CHAMBER ENGINEERING CHALLENGES
27% Semiconductor

Process chamber 1  Kalrez® seals are temperature,

73%
Industrial Sight glass chemical and plasma resistant
Process
chamber 2  Kalrez® is specified by customers to
Adapter
minimize unexpected downtime
Semiconductor Investment Growth plate
200 Fab CapEx and Wafer Fab Equipment (WFE)(1)  >70% of Kalrez® focused on
O-ring 1 semiconductor applications
150 Vacuum
suction  Stable unit-driven growth with
100
$B

O-ring 2 mostly replacement sales

50 EMC sealing
ring  Significant industry investment for
0
2019 2020 2021 2022 2023 2024 2025 Square flange fab capacity and equipment
Capex WFE

LEADING MARKET POSITION BASED ON PRODUCT PERFORMANCE AND CUSTOMER PARTNERSHIPS

(1) Source: Gartner 5

DuPont Vespel® parts solve critical challenges in wear,
friction and light-weighting
Sales Distribution CUSTOM SOLUTIONS FOR CRITICAL
by Segment HIGH-VALUE APPLICATIONS INNOVATION PARTNER FOR
ENGINEERING CHALLENGES
Vespel® Parts, Shapes, Composites & Assemblies
16%

42%
 Vespel® parts are light-weight and
high-strength serving as critical
25%
enablers of next-gen aero engines
EXAMPLE: AEROSPACE APPLICATIONS
17%  37% growth in global commercial
aero fleet by 2030(1)
Aerospace  Future ICE and EV designs
Semiconductor demand reduction in noise,
Transportation vibration & harshness (NVH)
Industrial
 20-30% growth CAGR in electric
vehicles (EV) through 2030(2)

50+ YEARS OF APPLICATION DEVELOPMENT EXPERTISE – DIVERSE AND EXPANDING PORTFOLIO

(1) Boeing Commercial Market Outlook 2021-2040
6
(2) Source: International Energy Agency
 Innovative materials for high-growth next-gen
technologies enable new display designs
Sales Distribution by Segment
DISPLAY GROWTH IN NEW TECHNOLOGIES
DUPONT MATERIAL INNOVATIONS
11%
OLED

 >80% of portfolio targeting OLED

LED
31%
58% and Next Gen LED displays
Other Display Materials  Organic Light Emitting Diode
(OLED) technology for higher
efficiency, longer lifetime, and
Smartphone Display Material deeper color
 Silicone encapsulants for backlight
% of Growing material demand with increasing units in mini-LED
units display volume production
 Performance-enhancing organic
78%
58% materials for LCD display
36% New form factors use advanced materials; substrates/layers enabling flexible
OLED and Mini/Micro LED growing in
displays and greater resolution
2015 2020 2025 adoption across applications
LCD OLED

LEADING POSITION WITH OLED AND NEW MATERIALS DESIGNED FOR ADVANCED DISPLAY TECHNOLOGIES

Source: OMDIA, DuPont analysis

7
Note: LCD (Liquid Cristal Display), OLED (Organic Light Emitting Diode)
DuPont LIVEOTM silicone material science and
application know-how enables advances in healthcare
Sales Distribution SILICONE MATERIALS:
by Segment DUPONT LIVEO™ APPLICATIONS GROWTH IN BIOPHARMA &
PROCESSING TECHNOLOGY
DuPont LIVEOTM is shifting mix to serve
higher-growth / higher-margin segments
35%  16% CAGR(1) from 2020 to 2027 in biopharma
40%
single-use technology driven by new generations
of vaccines and personalized therapies
 Increasing use of silicone-based solutions in
25% biologics manufacturing to reduce risks
LIVEOTM Assembly for
Biopharma Processing  Expanding portfolio beyond silicone tubing to
Biopharma Processing other solutions
Pharma Solutions  Investing in new capacity at world-class
manufacturing sites
Medical Devices

LEADING MARKET POSITION FROM STRONG PRODUCT QUALITY AND REGULATORY CAPABILITIES
(1) Sources: BioPlan annual reports, BCC Market Research, GrandView, DuPont analysis; https://www.reportsanddata.com/report-detail/biologics-market
8
Key
takeaways
Consistent top-line growth Technology leader with a
of approximately 5 to 7 long history of operational
percent with strong cash and quality excellence
flow

Resilient portfolio with Customer-specified Significant room for

leading positions in solutions and design portfolio expansion
growth markets partnerships leading to
sticky relationships

9
  Thursday, March 17, 2022
• J.P. Morgan Industrials Conference
Upcoming
Events  Thursday, March 24, 2022
• Water Solutions (W&P) Teach-In

E&I business line teach-ins (Semiconductor Technologies, Interconnect Solutions

and Industrial Solutions) available for replay at www.investors.dupont.com

10
 Safe Harbor Statement
Overview

On November 2, 2021, DuPont announced it has entered definitive agreements to acquire Rogers Corporation (“Rogers”), (the “Intended Rogers Acquisition”). On January 25, 2022, Rogers shareholders approved the
transaction. Closing, is expected by the end of the second quarter 2022, subject to regulatory approvals and customary closing conditions.

On February 18, 2022 , DuPont announced that it has entered into definitive agreements to divest a majority of its Mobility & Materials segment, excluding certain Advanced Solutions and Performance Resins businesses, to
Celanese Corporation (“Celanese”), (the “M&M Divestiture”). Closing is expected around the end of 2022, subject to regulatory approvals and customary closing conditions.

The Company also announced on February 18, 2022 that its Board of Directors has approved the divestiture of the Delrin® acetal homopolymer (H-POM) business. In addition to the entry into definitive agreements, the
Company anticipates that the closing of the sale of Delrin® would be subject to regulatory approvals and other customary closing conditions, (the “Delrin® Business Divestiture and together with the M&M Divestiture, the “M&M
Divestitures”).

Cautionary Statement Regarding Forward Looking Statements

This communication contains "forward-looking statements" within the meaning of the federal securities laws, including Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of
1934, as amended. In this context, forward-looking statements often address expected future business and financial performance and financial condition, and often contain words such as "expect," "anticipate," "intend," "plan,"
"believe," "seek," "see," "will," "would," "target," and similar expressions and variations or negatives of these words.

Forward-looking statements address matters that are, to varying degrees, uncertain and subject to risks, uncertainties, and assumptions, many of which that are beyond DuPont's control, that could cause actual results to differ
materially from those expressed in any forward-looking statements. Forward-looking statements are not guarantees of future results. Some of the important factors that could cause DuPont's actual results to differ materially
from those projected in any such forward-looking statements include, but are not limited to: (i) the parties’ ability to meet expectations regarding the timing, completion and accounting and tax treatments of the M&M Divestiture
to Celanese, including (x) any failure to obtain necessary regulatory approvals, anticipated tax treatment or to satisfy any of the other conditions to the proposed transaction, (y) the possibility that unforeseen liabilities, future
capital expenditures, revenues, expenses, earnings, synergies, economic performance, indebtedness, financial condition, losses, future prospects, business and management strategies could impact the value, timing or pursuit
of the proposed transaction, and (z) risks and costs and pursuit and/or implementation, timing and impacts to business operations of the separation of business lines in scope for the M&M Divestiture to Celanese, (ii) the timing
and outcome of the Delrin® Business Divestiture, including entry into definitive agreements, and the risks, costs and ability to realize benefits from the pursuit of the Delrin® Business Divestiture; (iii) ability to achieve anticipated
tax treatments in connection with mergers, acquisitions, divestitures and other portfolio changes actions and impact of changes in relevant tax and other laws; (iv) indemnification of certain legacy liabilities; (v) risks and costs
related to each of the parties respective performance under and the impact of the arrangement to share future eligible PFAS costs by and between DuPont, Corteva and Chemours; (vi) failure to timely close on anticipated terms
(or at all), realize expected benefits and effectively manage and achieve anticipated synergies and operational efficiencies in connection with mergers, acquisitions, divestitures and other portfolio changes including the Intended
Rogers Acquisition and the M&M Divestitures; (vii) risks and uncertainties, including increased costs and the ability to obtain raw materials and meet customer needs, related to operational and supply chain impacts or
disruptions, which may result from, among other events, the COVID-19 pandemic and actions in response to it, and geo-political and weather related events; (viii) ability to offset increases in cost of inputs, including raw
materials, energy and logistics; and (ix) other risks to DuPont's business, operations; each as further discussed in DuPont’s most recent annual report and subsequent current and periodic reports filed with the U.S. Securities
and Exchange Commission. Unlisted factors may present significant additional obstacles to the realization of forward-looking statements. Consequences of material differences in results as compared with those anticipated in
the forward-looking statements could include, among other things, business or supply chain disruption, operational problems, financial loss, legal liability to third parties and similar risks, any of which could have a material
adverse effect on DuPont’s consolidated financial condition, results of operations, credit rating or liquidity. You should not place undue reliance on forward-looking statements, which speak only as of the date they are made.
DuPont assumes no obligation to publicly provide revisions or updates to any forward-looking statements whether as a result of new information, future developments or otherwise, should circumstances change, except as
otherwise required by securities and other applicable laws.

11
 © 2022 DuPont de Nemours, Inc. All rights reserved.
© 2020 DuPont. All rights reserved. DuPont™, the DuPont Oval Logo, and all trademarks and service marks denoted with ™, ℠ or ® are owned by affiliates of DuPont de Nemours, Inc. unless
otherwise noted. Nothing contained herein shall be construed as a representation that any recommendations, use or resale of the product or process described herein is permitted and complies
DuPont™, the DuPont Oval Logo, and all products, unless otherwise noted, denoted with ™, ℠ or ® are trademarks, service
with the rules or regulations of any countries, regions, localities, etc., or does not infringe upon patents or other intellectual property rights of third parties.

The information provided herein is basedmarks or registered

on data DuPont trademarks
believes to be reliable, to the best of
of itsaffiliates ofisDuPont
knowledge and derequest
provided at the Nemours, Inc.charge to our customers. Accordingly,
of and without
DuPont does not guarantee or warrant such information and assumes no liability for its use. If this product literature is translated, the original English version will control and DuPont hereby
disclaims responsibility for any errors caused by translation. This document is subject to change without further notice.